Skip to main content
Table of Contents
Print

Should Cannabis Be Used During CBT Sessions For Depression?Ā 

Author: Dr. Clarissa Morton, PharmD

The role ofĀ cannabis and CBT for depressionĀ is a developing area of interest. CognitiveĀ behaviouralĀ therapy (CBT) is one of the most effective psychological treatments for depressionĀ , helping patients reframe negative thought patterns and build coping strategies. Some individuals report that cannabis, particularly CBD, helps them feel calmer and more open during therapy, potentially enhancing engagement.Ā 

However, evidence remains limited. While CBD may support relaxation and reduce anxiety before sessions, higher doses of THC can impair memory, focus, and learning—skills central to CBT’s success. This makes careful consideration essential when thinking about combining the two. 

Cannabis And Therapy Outcomes 

Research into cannabis and CBT for depression considers whether cannabinoids could enhance, or in some cases hinder, therapeutic progress. 

Cognitive Behavioural Therapy 

CBD may support cognitive behavioural therapy by reducing pre-session stress and allowing patients to concentrate more effectively. In contrast, THC’s effects on memory could interfere with the structured learning process. 

Therapy Enhancement 

Some patients describe cannabis as offering therapy enhancement, helping them access emotions or reduce resistance in sessions. Yet results vary widely, and not all experiences are positive. 

Mood Improvement 

By easing stress and anxiety, cannabis may indirectly support mood improvement alongside CBT. Still, professionals emphasise that cannabis should never replace therapy itself but only be considered as a possible adjunct. 

In summary, while some patients believe cannabis may complement cannabis and CBT for depression, the evidence is not strong enough to recommend it as standard practice. More clinical studies are needed to understand benefits and risks. 

For individuals considering whether cannabis could be used with CBT, providers likeĀ LeafEaseĀ can offer professional consultations to explore safe andĀ personalisedĀ guidance.Ā 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical CannabisĀ and Depression.Ā 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.Ā 

Categories